Inspirna
If you can't fund the Phase 3 you designed, the design was wrong. Downsize the trial or partner years earlier.
Inspirna was a Biotech / Oncology startup founded in 2014 in USA. It raised $210M before collapsing in 2025 — 11 years of runway burned. IdeaProof's AI Failure Score: 72/100, driven by failed to raise phase 3 funding; folded before pivotal trial. The shutdown affected employees, investors, and the broader Biotech / Oncology ecosystem. This case study breaks down the timeline, root causes, competitors that won, and replicable lessons for founders validating similar ideas today.
Why did Inspirna fail?
Inspirna failed in 2025 after 11 years of operation, losing $210M in raised capital. The root cause was failed to raise phase 3 funding; folded before pivotal trial. Key lesson: If you can't fund the Phase 3 you designed, the design was wrong. Downsize the trial or partner years earlier.
2014 → 2025
$210M
Biotech / Oncology
USA
IdeaProof AI Failure Score
What Happened: The Timeline
2014
Inspirna founded in USA. Positioned in biotech / oncology.
2014-2016
Raises $210M from Deerfield Management, Cormorant Asset Management, Woodline Partners.
2024
Warning signs emerge: phase 3 financing round failed.
2025
Shutdown announced. Root cause: failed to raise phase 3 funding; folded before pivotal trial.
Root Causes
Inspirna (formerly Rgenta Therapeutics, then Rgenix) was a New York City oncology drug developer led by well-known executives and backed by Deerfield, Cormorant and Woodline, with ~$210M raised. It was preparing for a Phase 3 pivotal cancer trial when in March 2025 Endpoints News reported the company was folding after failing to raise the Phase 3 financing round. The Phase 3 was designed at scale for a broad population; investors preferred a smaller, targeted trial the company felt could not read out convincingly. Inspirna illustrates a common late-stage biotech failure mode: trial design mismatched with capital availability.
Key Lessons Learned
Frequently Asked Questions
Sources & Confidence
Every data point is tagged with its source type and our confidence in it. How we grade sources.
Could This Failure Have Been Prevented?
IdeaProof's AI validates market demand, competitive positioning, and business model viability in minutes — catching the exact issues that sank Inspirna.